Empo Health develops easy-to-use in-home foot monitoring solutions that empower people with diabetes and their care teams to detect and manage diabetic foot ulcers earlier. The company combines the Empo Footprint imaging scale with the Empo Remote Health Link monitoring service to capture high-resolution images of patients' feet, deliver them to clinicians, and integrate routine monitoring into patients' daily lives.

Over 20 million people in the U.S. live with diabetic neuropathy, placing them at heightened risk for foot ulcers, hospitalization, amputation, and premature death. Empo's mission is to make regular at-home foot monitoring practical and scalable so issues are identified sooner and appropriate treatment and care coordination can reduce amputations and other adverse outcomes.

Empo partners with healthcare providers and payors and supports patients directly. Their product is designed to be simple for patients (step-on use) and actionable for providers, improving clinical workflows, monitoring adherence, and enabling early interventions that improve outcomes.